Suppr超能文献

在食管鳞状细胞癌中,升高的FAM84B通过与NPM1相互作用促进细胞增殖。

Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma.

作者信息

Wang Fang, Cheng Caixia, Wang Xinhui, Chen Fei, Li Hongyi, Zhou Yan, Wang Yanqiang, Hu Xiaoling, Kong Pengzhou, Zhang Ling, Cheng Xiaolong, Cui Yongping

机构信息

Key Laboratory of Cellular Physiology of the Ministry of Education & Department of Pathology, Shanxi Medical University, 030001, Taiyuan, Shanxi, P. R. China.

Department of Pathology, the First Hospital, Shanxi Medical University, 030001, Taiyuan, Shanxi, P. R. China.

出版信息

Cell Death Discov. 2022 Apr 8;8(1):182. doi: 10.1038/s41420-022-00984-9.

Abstract

Family with sequence similarity 84, member B (FAM84B) is a significant copy number amplification gene in the 8q24.21 locus identified by our previous WGS study in esophageal squamous cell carcinoma (ESCC). However, its clinical relevance and potential mechanisms have been elusive. Here, we performed the association analyses between FAM84B and clinicopathological features using 507 ESCC samples. The results indicated that, compared with the FAM84B patients the FAM84B patients showed a more aggressive and a worse prognosis. A significant correlation was discovered between the expression level of FAM84B and FAM84B in the ESCC cohort. Furthermore, we found that the forced expression change of FAM84B can influence ESCC cell proliferation and cell-cycle status, which is probably mediated by NPM1. A direct interaction between FAM84B and the C-terminal (189-294aa) of NPM1 was identified, which increased the NPM1 nuclear expression. Over-expression of NPM1 could inhibit the CDKN2A protein expression, which might affect the ESCC cell cycle. Our results indicate FAM84B CNA may be a potential diagnostic and therapeutic biomarker in ESCC, meanwhile, reveal a novel mechanism of FAM84B that promotes tumorigenesis via interacting with NPM1 and suppressing CDKN2A.

摘要

家族序列相似性84成员B(FAM84B)是我们之前在食管鳞状细胞癌(ESCC)的全基因组测序研究中确定的8q24.21位点上一个重要的拷贝数扩增基因。然而,其临床相关性和潜在机制一直不清楚。在此,我们使用507例ESCC样本进行了FAM84B与临床病理特征之间的关联分析。结果表明,与FAM84B低表达患者相比,FAM84B高表达患者表现出更具侵袭性和更差的预后。在ESCC队列中发现FAM84B的表达水平与拷贝数扩增之间存在显著相关性。此外,我们发现FAM84B的强制表达变化可影响ESCC细胞增殖和细胞周期状态,这可能由核仁磷酸蛋白1(NPM1)介导。确定了FAM84B与NPM1的C末端(189 - 294aa)之间存在直接相互作用,这增加了NPM1的核表达。NPM1的过表达可抑制细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A)蛋白表达,这可能影响ESCC细胞周期。我们的结果表明FAM84B拷贝数扩增可能是ESCC中一种潜在的诊断和治疗生物标志物,同时揭示了FAM84B通过与NPM1相互作用并抑制CDKN2A促进肿瘤发生的新机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验